DSpace at RU >

Browsing by Author Zittoun, R.

Full Text	Issue Date	Title	Author(s)
	2009	Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.	Mandelli, F.; Vignetti, M.; Suciu, S.; Stasi, R.; Petti, M.C., et al
	2004	Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial.	Labar, B.; Suciu, S.; Zittoun, R.; Muus, P.; Marie, J.P., et al
	1997	MLL cleavage occurs in approximately 5% of de novo acute myeloid leukemia, including in patients analyzed before treatment induction	Macintyre, E.; Bourquelot, P.; Leboeuf, D.; Rimokh, R.; Archimbaud, E., et al
	1997	Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial	Zittoun, R.; Suciu, S.; Watson, M.A.; Solbu, G.; Muus, P., et al
	1997	A european perspective on haematopoietic growth factors in haemato-oncology : report of an expert meeting of the EORTC	Croockewit, A.J.; Bronchud, M.H.; Aapro, M.S.; Bargetzi, M.; Crown, J., et al
	1997	Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)	Lowenberg, B.; Suciu, S.; Archimbaud, E.; Ossenkoppele, G.J.; Verhoef, G.E.G., et al
	1997	A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)	Willemze, R.; Suciu, S.; Archimbaud, E.; Muus, P.; Stryckmans, P., et al
	1996	Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (06901) of the EORTC Leukemia Cooperative Group	Witte, T.J.M. de; Suciu, S.; Selleslag, D.; Labar, B.; Roozendaal, K.J., et al
	1996	Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial	Keating, S.; Suciu, S.; Witte, T.J.M. de; Mandelli, F.; Willemze, R., et al
	1996	Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for research and treatment of cancer leukemia cooperative group	Zittoun, R.; Suciu, S.; Mandelli, F.; Witte, T.J.M. de; Thaler, J., et al
	1995	Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration : a pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)	Witte, T.J.M. de; Suciu, S.; Peetermans, M.; Fenaux, P.; Strijckmans, P., et al
	1995	Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia	Zittoun, R.; Mandelli, F.; Willemze, R.; Witte, T. de; Labar, B., et al